London-headquartered Vicebio has initiated a Phase I clinical trial (NCT06556147) of its bivalent vaccine VXB-241 that targets both RSV and human metapneumovirus (hMPV) viruses. The trial will ...

While Human Metapneumovirus (HMPV) is being much talked about, doctors are seeing a good number of children requiring hospital care for those affected with RSV (respiratory syncytial virus ...

HMPV has been found worldwide. Symptoms exhibited by patients are similar to those in respiratory syncytial virus-infected patients. Clinical symptoms vary, but it is a significant cause of lower ...

Icosavax’s pipeline of respiratory disease vaccines is headed by IVX-A12, a virus-like particle (VLP) shot that targets both RSV and human metapneumovirus (hMPV), two major causes of serious ...

Continued innovation and investment in molecular diagnostics will ensure broader access and better preparedness for HMPV, its variants and other respiratory illnesses. HMPV Virus Cases LIVE Blog ...